Identification of differentially expressed genes in rat aortic allograft vasculopathy

American Journal of Pathology

Volumn 149, Issue 2, 1996, Pages 597-611

  Chen, Jianmin ^a   Myllärniemi, Marjukka ^b   Akyürek, Levent M ^c   Häyry, Pekka ^b   Marsden, Philip A ^a   Paul, Leendert C ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; DNA; FERRITIN; IMMUNOGLOBULIN J CHAIN; MESSENGER RNA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; AORTA GRAFT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD45; AORTA, ABDOMINAL; BASE SEQUENCE; BLOTTING, NORTHERN; DNA, COMPLEMENTARY; ENDOMETRIAL HYPERPLASIA; FEMALE; FERRITINS; GENE EXPRESSION REGULATION; IMMUNOCHEMISTRY; IMMUNOENZYME TECHNIQUES; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TUNICA INTIMA;

EID: 0030038599     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Balk AHMM, Weimar W: Chronic heart graft rejection in the clinical setting. Organ Transplantation: Long-Term Results. Edited by LC Paul, K Solez. New York, Marcel Dekker, 1992, pp 187-195
2. Billingham ME: Pathology and etiology of chronic rejection of the heart. Clin Transplant 1994, 8:289-292
3. Ross R: The pathogenesis of atherosclerosis: perspective for the 1990s. Nature 1993, 362:801-809
4. Häyry P, Mennander A, Raisänen-Sokolowski A, Ustinov J, Lemström K, Aho P, Yilmaz S, Lautenschlager I, Paavonen T: Pathophysiology of vascular wall changes in chronic allograft rejection Transplant Rev 1993, 7:1-20
5. Häyry P, Myllärniemi M, Aavik E, Alatalo S, Aho P, Yilmaz S, Raisänen-Sokolowski A, Cozzone G, Jameson BA, Baserga R: Stable D-peptide analogue of insulin-like growth factor-1 inhibits smooth muscle proliferation after carotid ballooning injury in the rat. FASEB J 1995, 9: 1336-1344
6. Russell ME, Fujita M, Masek MA, Billingham ME: Cardiac graft vascular disease. Transplantation 1993, 56: 762-763
7. Nakagawa T, Sukhova GK, Rabkin E, Winters GL, Schoen FJ, Libby P: Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation 1995, 92:987-993
8. Cramer DV, Qian SQ, Harnaha J, Chapman FA, Estes LW, Starzl TE, Makowka L: Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis. Transplantation 1989, 47:414-419
9. Cramer DV, Chapman FA, Wu GD, Harnaha JB, Qian SQ, Makowka L: Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation 1990, 50:554-558
10. O'Hair DP, McManus RP, Komorowski R: Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil. Ann Thorac Surg 1994, 58:1311-1315
11. MacDonald AS, Sabr K, MacAuley MA, McAllister VC, Bitter-Suermann H, Lee L: Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat. Transplant Proc 1994, 26:3244-3245
12. Gregory CR, Huang X, Pratt RE, Dzau VJ, Shorthouse R, Billingham ME, Morris RE: Treatment with rapamycin and mycophenolic acid reduces arterial intimai thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995, 59:655-661
13. Shin YT, Adams DH, Wyner LR, Akalin E, Sayegh MH, Karnovsky MJ: Intrathymic tolerance in the Lewis-to-44 chronic allograft rejection model. Transplantation 1995, 59:1647-1653
14. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R: Insulin-like growth factor-1 and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994, 93:1266-1274
15. Welsh J, Chada K, Dalal SS, Cheng R, Ralph D, McClelland M: Arbitrarily primed PCR fingerprinting of RNA. Nucleic Acids Res 1992, 20:4965-4970
16. Welsh J, McClelland M: Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 1990, 18:7213-7218
17. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971
18. Autieri MV, Feuerstein GZ, Yue TL, Ohlstein EH, Douglas SA: Use of differential display to identify differentially expressed mRNAs induced by rat carotid artery balloon angioplasty. Lab Invest 1995, 72:656-661
19. Utans U, Liang P, Wyner LR, Karnovsky MJ, Russell ME: Chronic cardiac rejection: identification of five up-regulated genes in transplanted hearts by differential mRNA display. Proc Natl Acad Sci USA 1994, 91: 6463-6467
20. Paul LC, Grothman GT, Benediktsson H, Davidoff A, Rozing J: Macrophage subpopulations in normal and transplanted heart and kidney tissues in the rat. Transplantation 1992, 53:157-162
21. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979, 18:5294-5299
22. Liang P, Pardee AB: Recent advances in differential display. Curr Opin Immunol 1995, 7:274-280
23. Flowers MA, Wang Y, Stuart RJ, Patel B, Marsden PA: Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells. Am J Physiol 1995, 269:H1988-1997
24. Aherne WA, Dunnill MS: Morphometry London, Edward Arnold, 1982, pp 1-205
25. Akyürek LM, Funa K, Wanders A, Larsson E, Fellström BC: Inhibition of transplant arteriosclerosis in rat aortic grafts by low molecular weight heparin derivatives. Transplantation 1995, 59:1517-1524
26. Häyry P, Raisanen A, Ustinov J, Mennander A, Paavonen T: Somatostatin analog Lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J 1993, 7:1055-1060
27. Liang P, Averboukh L, Pardee AB: Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 1993, 21:3269-3275
28. Matsuuchi L, Cann GM. Koshland ME: Immunoglobulin J-chain gene from the mouse. Proc Natl Acad Sci USA 1986, 83:456-460
29. Lansford RD, McFadden HJ, Siu ST, Cox JS, Cann GM, Koshland ME: A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene. Proc Natl Acad Sci USA 1992, 89:5966-5970
30. Nadeau KC, Azuma H, Tilney NL: Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 1995, 92:8729-8733
31. Xu G-P, Sharma VK, Li B, Bologa R, Li Y, Mouradian J, Wang J, Serur D, Rao V, Stenzel KH, Suthanthiran M: Intragraft expression of IL-10 messenger RNA: a novel correlate to renal allograft rejection. Kidney Int 1995, 48:1504-1507
32. Rolink A, Andersson J, Ghia P, Grawunder U, Haasner D, Karasuyama H, Ten Boekel E, Winkler TH, Melchers F: B-cell development in mouse and man. Immunologist 1995, 3:125-151
33. Xu QB, Oberhuber G, Gruschwitz M, Wick G: Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 1990, 56:344-359
34. Tiisala S, Leszczynski D, Halttunen J, Nemlander A, Paavonen T, Renkonen R, Häyry P: The frequency of B cells secreting antibodies against donor MHC antigens in rats rejecting renal allografts. Transplant Int 1990, 3:86-91
35. Nadasdy T, Krenacs T, Kalmar KN, Csajbok E, Bouda K, Ormos J: Importance of plasma cells in the infiltrate of renal allografts: an immunohistological study. Pathol Res Pract 1991, 187:178-183
36. Russell PS, Chase CM, Winn HJ, Colvin RB: Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994, 152:5135-5141
37. Stach RM, Rowley DA: A first or dominant effect. II. Induced immunoglobulin carries transforming growth factor-β and suppresses cytolytic T cell responses to unrelated antigens. J Exp Med 1993, 178:841-852
38. Chavrier P, Gorvel J-P, Bertoglio J: An immunologist's look at the Rho and Rab GTP-binding proteins, Immunol Today 1993, 14:440-444
39. Stenmark H, Parton RG, Steele-Mortimer O, Lutcke A, Gruenberg J, Zerial M: Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J 1994, 13:1287-1296
40. Santos E, Nebreda AR: Structural and functional properties of ras proteins. FASEB J 1989, 3:2151-2163
41. Bokoch GM, Der CJ: Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J 1993, 7:750-759
42. Indolfi C, Avvedimento EV, Rapacciuolo A, DiLorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G, Chiariello M: Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med 1995, 1:541-545
43. O'Donnell MP, Kasiske BL, Massy ZA, Guijarro C, Swan SK, Keane WF: Isoprenoids and ras: potential role in chronic rejection. Kidney Int 1995, 48(suppl 52):S29-S33
44. White K, Munro HN: Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J Biol Chem 1988, 263:8938-8942
45. Chou CC, Gatti RA, Fuller ML, Concannon P, Wong A, Chada S, Davis RC, Salser WA: Structure and expression of ferritin genes in a human promyelocytic cell line that differentiates in vitro. Mol Cell Biol 1986, 6:566-573
46. Beaumont C, Jain SK, Bogard M, Nordmann Y, Drysdale J: Ferritin synthesis in differentiating Friend erythroleukemic cells. J Biol Chem 1987, 262:10619-10623
47. Liau G, Chan LM, Feng P: Increased ferritin gene expression is both promoted by cAMP and a marker for growth arrest in rabbit vascular smooth muscle cells. J Biol Chem 1991, 266:18819-18826
48. Klausner RD, Rouault TA, Harford JB: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993, 72:19-28
49. Juckett MB, Balla J, Balla G, Jessurun J, Jacob HS, Vercellotti GM: Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 1995, 147:782-789
50. . Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN: Translational control during the acute phase response. J Biol Chem 1990, 265: 14572-14578
51. Rela M, Smith REA, De Belder AJ, Wong A, Villa LM, Beesley JE, Heaton ND, Tan KC, Martin JF: Nitric oxide synthase induction and chronic cardiac allograft rejection. Transplant Proc 1995, 27:2073
52. Russell ME, Wallace AF, Wyner LR, Newell JB, Karnovsky MJ: Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation 1995, 92:457-464
53. Oria R, Sanchez L, Houston T, Hentze MW, Liew FY, Brock JH: Effect of nitric oxide on expression of transferrin receptor and ferritin and on cellular iron metabolism in K562 human erythroleukemia cells. Blood 1995, 85:2962-2966
54. Chen CY, Xu N, Shyu AB: mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 1995, 15:5777-5788